Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
Open Access
- 27 October 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (59) , 100216-100226
Abstract
Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-B signaling Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signalingKeywords
This publication has 31 references indexed in Scilit:
- MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1Gastroenterology, 2017
- NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growthNature Immunology, 2017
- Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s diseaseScientific Reports, 2016
- Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated CancerCancer Cell, 2013
- Apigenin and its impact on gastrointestinal cancersMolecular Nutrition & Food Research, 2012
- Flavones induce neutrophil apoptosis by down‐regulation of Mcl‐1 via a proteasomal‐dependent pathwayThe FASEB Journal, 2012
- The Dual Role of Inflammation in Colon CarcinogenesisInternational Journal of Molecular Sciences, 2012
- Inflammasomes in Intestinal Inflammation and CancerGastroenterology, 2011
- Colitis-associated cancer: the dark side of inflammatory bowel disease: Figure 1Gut, 2011
- Inflammatory bowel disease: cause and immunobiologyThe Lancet, 2007